Form D · Biotechnology
Microterra Biotec Inc.
Mexico City, O5 · CIK 0002035421
Offering snapshot reported Sep 25, 2024 · SEC filing
- Reported sold
- $4.62M Offering amount: $5.7M
- Investors reported
- 27 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 13, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 25, 2024 | Initial | $4,619,156 | No comparison | 27 | SEC filing |
| Sep 9, 2024 | Initial | $5,079,606 | No comparison | 27 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-524994
Source: Form D, filed Sep 25, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marissa Cuevas | Director, Executive |
| Pablo Fernandez | Director |
| Gabriel Wilmoth | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Amsterdam 316 Hipodromo, Cuauhtemoc
Mexico City, O5, 06100
Mexico City, O5, 06100